Table 1. Clinical characteristics of dilated cardiomyopathy (DCM) patients.
| DCM (n = 13) | DCM (n = 19) | |
|---|---|---|
| RNA-sequencing | Western Blot | |
| Age (years) | 51 ± 11 | 47 ± 12 |
| Gender male (%) | 92 | 84 |
| NYHA class | 3.4 ± 0.4 | 3.5 ± 0.4 |
| BMI (kg/m2) | 27 ± 5 | 25 ± 5 |
| BNP (pg/mL) | 8529 ± 11577 | 6025 ± 11818 |
| Hemoglobin (mg/dL) | 13 ± 3 | 13 ± 3 |
| Hematocrit (%) | 39 ± 8 | 40 ± 6 |
| Total cholesterol (mg/dL) | 147 ± 37 | 145 ± 44 |
| Prior hypertension (%) | 17 | 29 |
| Prior smoking (%) | 50 | 67 |
| Diabetes mellitus (%) | 17 | 13 |
| Heart rhythm sinusal (%) | 69% | 74% |
| EF (%) | 20 ± 7 | 22 ± 8 |
| FS (%) | 11 ± 4 | 12 ± 4 |
| LVESD (mm) | 71 ± 12 | 66 ± 12 |
| LVEDD (mm) | 80 ± 11 | 75 ± 12 |
| Left ventricle mass index (g/m2) | 241 ± 77 | 208 ± 72 |
| Duration of disease (months) | 75 ± 68 | 80 ± 69 |
DCM, dilated cardiomyopathy; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; FS, fractional shortening; LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter.